NSAIDs May Reduce GERD Subgroup’s Risk Of Esophageal Cancer – Lancet
This article was originally published in The Tan Sheet
Executive Summary
Individuals with Barrett's esophagus who did not take NSAIDs regularly had more than double the risk of esophageal cancer compared to regular users, according to an observational study published in the November issue of The Lancet Oncology